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Opinion statement
Patients with advanced cancer and their families commonly seek information about
prognosis to aid decision-making in medical (e.g. surrounding treatment), psychological
(e.g. saying goodbye), and social (e.g. getting affairs in order) domains. Oncologists
therefore have a responsibility to identify and address these requests by formulating and
sensitively communicating information about prognosis. Current evidence suggests that
clinician predictions are correlated with actual survival but tend to be overestimations. In
an attempt to cultivate prognostic skills, it is recommended that clinicians practice
formulating and recording subjective estimates of prognosis in advanced cancer patient’s
medical notes. When possible, a multi-professional prognostic estimate should be sought
as these may be more accurate than individual predictions alone. Clinicians may consider
auditing the accuracy of their predictions periodically and using feedback from this
process to improve their prognostic skills.
Clinicians may also consider using validated prognostic tools to complement their
clinical judgements. However, there is currently only limited evidence about the
comparative accuracy of different prognostic tools or the extent to which these
measures are superior to clinical judgement. Oncologists and palliative care physicians
should ensure that they receive adequate training in advanced communication skills,
which builds upon their pre-existing skills, to sensitively deliver information on
prognosis. In particular, clinicians should acknowledge their own prognostic
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uncertainty and should emphasise the supportive care that can continue to be pro-
vided after stopping cancer-directed therapies.
Introduction
Prognostication is the process of making predictions
about future health outcomes, usually about predicting
length of survival. Patients with advanced cancer fre-
quently express a desire for prognostic information [1].
However, simply being told that one is “terminal” or
“incurable” does not usually provide sufficient informa-
tion for patients or families to make detailed plans for
the future [1, 2]. Even if patients do not wish to know
exact timescales, they may want to have prognostic in-
formation to inform treatment discussions, undertake
advance care planning, or help with decision-making [3,
4]. Clinicians commonly find it difficult to make these
predictions and to discuss them with patients and rela-
tives, leading to unmet information needs [5, 6]. Com-
munication in this area is complex and requires skill and
experience, particularly in finding the balance between
conveying useful information about expected
timeframes, while also explaining the inherent uncer-
tainty in such predictions. Advanced communication
skills should therefore be considered an essential ele-
ment in the process of prognostication [7].
The prognosis of an individual patient is liable to
change over time and to be influenced by biological,
clinical, and social factors beyond diagnosis and stage of
disease [8, 9]. Therefore, it is important for oncologists
to develop and maintain skills in predicting survival
even when the disease has become incurable and
disease-directed treatment options are limited or non-
existent. This is distinct from the more common practice
of staging cancers to derive median survival estimates at
diagnosis or the use of prognostic markers to predict
response to treatment.
A prognostic estimate can be formulated using a
clinician’s experience and knowledge to make a judge-
ment; this is known as a clinical prediction of survival.
Although widely used, there are concerns about the
subjective nature of this approach, which makes it diffi-
cult to reproduce and teach. Also, subjective judgements
tend to be inaccurate and over-optimistic [10, 11••, 12].
Therefore, more “objective” scales and tools have been
developed to support clinical predictions [13, 14••].
The aim of this paper is to evaluate the recent litera-
ture on prognostication for patients with advanced can-
cer and to suggest ways in which physicians can improve
their own clinical practice in formulating and commu-
nicating prognostic estimates.
Clinical prognostic estimates
Clinical prognostic estimates usually take one of two formats: temporal (how
long?) or probabilistic (how likely?). Temporal predictions can either be spe-
cific (e.g. “two days”) or can use broader categories (e.g. “one to two months”).
Probabilistic predictions estimate the likelihood of patients surviving to specific
time points (e.g. “70% chance of surviving twoweeks”). An alternative option is
for clinicians to ask themselves the Surprise Question (SQ); “would I be
surprised if this patient were to die in the next 6-12 months?” [15]. The SQ
was developed to prompt clinicians to consider whether patients would benefit
from a shift in focus of care or from referral to specialist palliative care services,
rather than as a method of prognostication per se. The original SQ has been
modified to use different time frames (e.g. 30 days) [16, 17], or to consider
survival rather than death; “would I be surprised if this patient were to be alive
in the next 6-12 months?” [18, 19]. The SQ is a prompt for introspection,
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encouraging clinicians to consider the possibility that the patient may die in the
foreseeable future rather than asking them to make a specific prediction about
how long they will live.
How accurate are clinical predictions of survival?
Temporal and probabilistic predictions
There is a growing body of evidence about the accuracy of clinician predictions
of survival. In preparation for this review, the authors identified two relevant
systematic reviews [10, 11••] and ten further articles published in the last
4 years (summarised in Table 1) [20–29].
Clinician predictions are correlated with actual survival, but there is a wide
variation in reported accuracy, with a general tendency to overestimate [10,
11••, 12, 20–23]. Clinicians’ specific predictions range from underestimating by
half to a sixfold overestimation [10, 11••]. One large prospective cohort study of
2036 locally advanced or metastatic cancer patients accessing palliative care
services found that 45% predictions were overestimates, 35% accurate, and
20% underestimates [20].
There is a lack of consensus in the literature about what constitutes an
“accurate” prediction, which makes interpretation of study results challenging.
For example, should a prediction of 12 weeks be considered “accurate” if the
patient dies 2 weeks before or after this? For specific temporal predictions, a
common approach is to regard a prognosis as accurate if actual survival falls
within ± 33% of the prediction [20, 21, 25, 30]. One limitation of this defini-
tion is that the magnitude of the absolute permissible error is small when the
estimated prognosis is short and is fairly large when the estimated prognosis is
longer. Thus, a clinical prediction of survival of 3 daysmay be judged inaccurate
if the patient dies in less than 48 h, whereas a prediction of 3 months may be
considered accurate even if the patient dies 4 weeks earlier than expected. The
level of “inaccuracy” that is clinically significant remains unclear; at what point
does a more “accurate” prognosis alter the management plan or come to be
considered important by patients or their relatives?
The issue of defining “accuracy” is magnified for probabilistic estimates.
How, for instance, should one judge the accuracy of a prediction that a patient
has 40% chance of surviving 2 weeks? A similar conundrum confronts weather
forecasters who often provide probabilistic estimates about, for example, the
chances of rain tomorrow. Professional forecasters tend to judge probabilistic
predictions using the Brier score [31]. This statistic reflects the degree to which a
prediction was correct or incorrect. Thus, a prediction of 90% is “more correct”
than a prediction of 70% if the event did actually occur. Brier scores range
between 0 (accurate) and 1 (inaccurate) with a score of 0.25 representing a
prediction of 50%. To our knowledge, only two studies have utilised the Brier
score to assess the accuracy of clinicians’ survival predictions [32, 33•]. The
mean Brier scores in these studies were 0.22 and 0.24 suggesting clinician’s
probabilistic predictions are slightly better than chance.
There is mixed evidence about whether certain health professionals are
better prognosticators than others or whether prognostic ability improves with
experience or seniority [11••]. However, there is some evidence that multi-
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professional estimates are more accurate than predictions made by individual
clinicians alone [34, 35]. In order to develop expertise, repeated “deliberate
practice” is required [36, 37]. Deliberate practice is a structured activity that
explicitly aims to improve performance by reflecting on the results of the
performance and gaining feedback. Therefore, one might suppose that clini-
cians ought to be able to improve the accuracy of their prognoses through
deliberate practice, although this hypothesis has not yet been tested.
In summary, despite the significant methodological difficulties associated
with judging prognostic accuracy, there is fairly consistent evidence that clini-
cians’ estimates correlate with actual survival. It appears that clinicians, regard-
less of the method of prognostication, do recognise when patients are
deteriorating.
Surprise Question
In systematic reviews, the SQ tends to be more accurate in cancer patients than
in patients with other life-threatening conditions [38, 39]. For patients with
cancer, the SQ has a positive predictive value (proportion of patients who die
when the clinician would not be surprised by their death) of 46.8–49.3%, a
negative predictive value (proportion of patients who survive when the clinician
would be surprised by their death) of 92.3–92.4%, a sensitivity (the proportion
of those correctly identified as dying) of 77.1%, and a specificity (proportion of
patients correctly identified as surviving) of 84.3%. Referral to palliative care
services is seldom based solely on having a poor prognosis; however, early
identification of palliative care patients is often triggered by a combination of
an expected prognosis of less than a year, combined with complex needs and/or
patient choice. Based on the psychometric properties of the SQ, its greatest
clinical value may lie in its negative predictive value for “screening out” patients
who are unlikely to need immediate referral to specialist palliative care services
(all other things being equal). It is, however, important to remember that
patients’ conditions change and that their prognosis is therefore in need of
regular re-appraisal.
Predicting imminent death
Are clinicians more accurate at predicting imminent death?
The concept of the “horizon effect” suggests that predictions ought to become
more accurate as the event being predicted draws closer [8]. There is conflicting
evidence in the literature about whether this is true for survival predictions [20,
22, 23, 30, 40–44]. In one study, clinicians were asked to provide repeated
specific temporal and probabilistic predictions for the following 24 and 48 h,
for patients admitted to a palliative care unit [30]. Temporal predictions were
defined as accurate if there was an error of less than ± 33%. Probabilistic
predictions were considered accurate if the clinician predicted ≤ 30% survival
and the patient died, or if the clinician predicted ≥ 70% survival and the patient
survived. Using these definitions, the authors concluded that probabilistic
estimates were more accurate than temporal predictions throughout the study
period. However, the accuracy of temporal predictions remained constant,
whereas the accuracy of probabilistic estimates worsened over the last 14 days
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of life. It is important to note that there have only been a limited number of
studies specifically investigating imminent death and the majority have been
conducted with patients who have already been identified as suitable for
palliative care referral or admission to a palliative care unit. Therefore, these
results may not hold true for unselected patient groups on general oncology
wards, especially those admitted with acute illnesses.
How do clinicians recognise the last days of life?
In a Delphi survey of international palliative care experts, there was over 50%
consensus that general deterioration in physical condition, reduced levels of
consciousness and cognition, decreased intake of fluid and food, skin changes,
altered emotional state, and specific patterns of breathing were features that
predicted when patients were entering the last hours and days of life [45].
However, many clinicians also feel they can intuitively recognise when a patient
is imminently dying. In semi-structured interviews, staff working in oncology
and cardiology wards were asked how they recognised patients whowere dying.
A range of symptoms, signs, imaging, and laboratory results were reported;
however, participants found it very difficult to describe how they assimilated
this information, commonly using terms such as having a “subconscious”
feeling or a “sixth sense’” that someone was about to die [46].
One way to better understand this so-called sixth sense is to use a research
method known as Judgement Analysis [47]. White and colleagues used this
approach to investigate which factors subconsciously influenced clinicians’
opinions about whether a patient was about to die within the next 72 h
[33•]. First, expert prognosticators were selected by their superior ability to
predict imminent death using clinical vignettes based on real patient cases;
the expert group had a mean Brier score of 0.184, reflecting better predictive
accuracy, compared to the whole groupmean of 0.237. Next, by altering clinical
parameters in fictional cases, the extent to which certain factors affected the
experts’ judgements could be established. The most influential factor in deter-
mining whether clinicians thought that patients were about to imminently die
was the Palliative Performance Scale (PPS), followed by the presence or absence
of Cheyne-Stokes breathing, general deterioration in the patient’s condition,
and level of sedation or agitation. Knowing what factors expert prognosticators
subconsciously use to formulate their predictions could potentially allowothers
to learn how to improve their estimates and to better recognise patients who are
imminently dying. A randomised controlled trial demonstrates that the use of
an online training programme can teach medical students to adopt similar
judgement strategies to experts [48]. However, further work will be required
to determine how the learning can be consolidated and whether the skills are
transferable from the classroom to clinic.
Anothermethod to understand how cliniciansmight recognise patients who
are imminently dying is to identify signs and symptoms that may be patho-
gnomonic of the dying process [49]. In a palliative care context, vital signs (e.g.
pulse, blood pressure, and oxygen saturations) have a low sensitivity or positive
predictive value for identifying those who are imminently dying, supporting the
practice of not routinely undertaking these observations in terminal care set-
tings [50]. However, Hui and colleagues have identified 13 clinical signs which
have high specificity (9 95%) and positive likelihood ratios (9 5) of predicting
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the final 72 h of life [51, 52]. Sensitivity of these signs rarely reached over 30%,
meaning their absence does not exclude imminent death, limiting their use in
clinical practice. Nonetheless, this work has informed the development of a
clinical tool to aid the diagnosis of impending death [53]. The initial model
combines the PPS as a tool to “rule out”, and “drooping of nasolabial folds” as a
specific sign to help “rule in”, impending death. A second model utilises the
other 12 signs identified in these studies. Further development and validation is
required before this approach can be recommended for clinical use.
Performance scales and prognostic tools
Performance or functional scales provide a systematic approach to evaluate
general well-being and ability to perform activities of daily living. They require
clinicians to match signs and symptoms of patients to a description of function
on a scale. The Karnofsky Performance Status (KPS) was the first to be devel-
oped and consists of single statements describing levels of function from 0 to
100% [54]; the Australian Modified KPS (AKPS) involves a slight alteration to
the phrasing of the statements to provide greater discrimination between certain
levels [55]. The PPS is also a modification of the Karnofsky, in which there are
five descriptive domains of function rather than a single descriptor [56]. In
contrast, the Eastern Cooperative Oncology Group (ECOG) performance scale
consists of only five levels [57]. Although not specifically devised as prognostic
tools, performance scales have been shown to correlate with survival in a variety
of settings [58–60].
In addition to performance scales, there are several tools that have been
specifically developedwith the aim to predict survival in patients with advanced
cancer. A recent systematic review identified seven suitably validated prognostic
tools [14••]: PPS [56], Palliative Prognostic Score (PaP) [61], DeliriumPalliative
Prognostic Score (D-PaP) [62], Palliative Prognostic Index (PPI) [63], Glasgow
Prognostic Score (GPS) [64], B12/CRP index (BCI) [65], and the Prognosis in
Palliative Care study predictor models (PiPS-A and PiPS-B) [34]. A summary of
these tools is provided in Table 2.
The place of prognostic tools in clinical practice has not yet been clearly
defined. Despite validation in relatively large numbers of advanced cancer
patients, which has demonstrated adequate discrimination and calibration,
there has been limited comparison of their performance against each other
or against clinicians’ predictions. This means it is often unclear whether these
tools perform better, worse, or the same as clinicians making predictions alone.
Moreover, it is not always easy to judge how the output of these prognostic
tools should be interpreted. The PaP, for instance, predicts whether patients
will have a G 30%, a 30–70%, or a 9 70% chance of surviving for the next
30 days. However, it is not clear how one should interpret these results on an
individual patient basis. What does a 30–70% chance of surviving 30 days
mean, and how should it be acted upon? Another problem that arises is
knowing which tool to use at what time. For example, the PaP and PPI both
provide results that may help to distinguish between whether patients will
survive for weeks or months, but neither is designed to identify when patients
are entering the final days of life. In addition, whether certain tools perform
better for patients with certain types of cancers is unknown. These limitations
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mean that existing prognostic tools cannot yet be recommended as a replace-
ment for clinicians’ predictions. For the moment, they should perhaps best be
considered as a means of triangulating, or cross-checking, clinicians’ own
clinical intuitions. They may also have a specific role when clinicians doubt
their own judgement or when an “objective” estimate is required, for example
for benchmarking of clinical services or determining inclusion and exclusion
criteria for clinical trials.
Communicating the prognostic estimate
Initiating prognostic discussions
Clinicians often find it difficult to talk about prognosis. Research has shown
clinicians sometimes “collude”with patients in creating false optimism, ormiss
or avoid cues from patients to talk about prognosis, moving straight to talking
about treatment options [66, 67]. The desire to focus on the positives is
understandable, particularly if it is not clear whether patients are ready to talk
about their prognosis. Clinicians therefore need strategies for initiating prog-
nostic conversations sensitively and to pick up on signs from patients that they
may be ready to talk about these issues. A recent study recorded hospice
outpatient consultations and showed that patients often displayed signs of
wanting to discuss prognosis when given the opportunity to influence the
consultation [68••, 69]. Patients frequently requested prognostic information
by using statements (e.g. “I don’t know when it’s coming”) rather than asking
direct questions. These statements allowed doctors to proceed to checking
patients’ current understanding and their perspectives, and to re-confirm their
readiness to hear a prognosis, before delivering it [68••].
Content of prognostic discussions
When a patient’s condition first becomes incurable, information about how
their function may deteriorate can be as important as life expectancy estimates
in allowing patients to pursue achievable goals and make practical plans for
future decline [70]. This information could also help inform their decisions
about treatment, as more aggressive care could reduce their ability to “live well”
until they die [71]. Over time, patients’ goals and prospects are likely to change
and so a step-wise approach of continued conversations about prognosis is
needed [72]. When patients reach the end of cancer-directed therapies, clini-
cians can focus on the care that will continue to be provided rather than
describing palliative and supportive care as “doing nothing” [73, 74]. Prognos-
tic discussions are an opportunity to reframe hope by being honest about the
difficulties the patient is facing and emphasising symptom control, continuing
relationships between clinicians and patients, and establishing achievable goals
that optimise quality of life [75]. As the disease progresses, function becomes
less relevant and time is more important to allow patients and relatives tomake
necessary arrangements, say goodbye, and provide the opportunity for relatives
to be present when the patient dies [76]. Research has also shown that families
often have a greater desire for prognostic information than patients when death
is imminent [77, 78]. It is therefore important to take the patient’s lead on how
much information to provide and be aware that separate conversations with
families may be needed [79].
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Prognostic uncertainty and lack of confidence discussing this with patients
are key reasons for clinicians to avoid prognostic conversations, and so learning
how to communicate an uncertain prognosis is important [80]. Current
evidence-based guidelines emphasise the importance of stating prognostic
uncertainty, but this is not the same as saying, “I do not know” or “it’s
impossible to judge” [81–83, 84••]. There is no evidence to suggest whether
providing estimates in temporal or probabilistic terms is the better approach
when communicating prognosis. However, the use of numerical information in
doctor-patient communication has been found to be contentious and the way
in which it is received shifts depending on context and stage of illness [85]. In
this study, patients felt statistics were used by clinicians with inadequate com-
munication skills to subvert the need to confront difficult emotions or discus-
sions. In practice, clinicians commonly use broad categories (e.g. days to weeks)
to discuss prognosis with advanced cancer patients [86]. This approach is a
useful way to couch prognostic uncertainty, as it provides patients and families
with a meaningful prognosis without giving a spuriously precise estimate [87].
Building skills to improve prognostic discussions
Recent trials of communication training for oncologists have shown some prom-
ising results. Interventions have shown improvement in patient-centred and
empathetic communication, earlier and more regular prognostic conversations,
and reductions in anxiety, but have struggled to improve prognostic awareness
and goal-concordant care [88, 89, 90•, 91]. Examination of real-life conversations
may help identify which elements of communication are most able to influence
the interaction. The “Real Talk” training programme provides learning points
based on analysis of naturally occurring conversations and uses clips to provide
real-life examples for trainees [92]. A similar approach has been used in commu-
nication training in other settings with promising results [93, 94]. Oncologists
and palliative care clinicians have more experience of discussing prognosis than
most specialists, and so the approach of basing recommendations on real-life
interactions, and building on clinicians’ pre-existing skills, could be a useful
learning strategy for other less-experienced clinicians. Any guidance or training
for oncologists about how to communicate prognosis must also provide them
with skills to respond appropriately to expressions of emotion. Derry and col-
leagues suggest various strategies to address emotional responses such as allowing
silence, validating emotions, and signposting to psychological services where
necessary [95•]. There are also a number of organisational factors that could
contribute to better communication of prognosis. These include allowing suffi-
cient time to discuss prognosis, allowing patients to ask questions [96], better
integration of oncology with palliative care [97], and support for clinicians
through encouragement of reflective practice [98].
Conclusion and recommendations
The ability to formulate and communicate a prognosis has advantages for the
patient, their families, and for clinical teams. Viewing prognostication as a
clinical skill invites us to understand that this is something that can be practised
and improved. Taking note of one’s own prognostic predictions and following
them up may help practitioners to practice reflectively and to hone their
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prognostic skills through feedback. When possible, a discussion with a multi-
professional team should be conducted as this may help refine the prognostic
estimate. Practitioners should also consider using prognostic tools to support
their decision-making, but should remain aware that the prognostic tools
themselves are also frequently inaccurate and should currently only be used
as an aid towards, rather than a replacement of, clinical decision-making.
Clinicians find talking about prognosis difficult, both in terms of how to
initiate these conversations and how to conduct them. Offering opportunities
to ask questions or encouraging patients to elaborate on their thoughts allows
them to steer the consultation, if they wish, towards prognostic discussions. If
patients make statements that hint that they are ready to start having prognostic
discussions, these should be explored, not ignored. Uncertainty is a key element
that needs to be conveyed during these conversations. On a practical level, this
can often be achieved by describing prognosis in terms of general time frames
(e.g. “hours”, “days”, “weeks”, “months”, or “years”) rather than using precise
estimates or complex statistical concepts such as probability or risk.
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